Opportunity Information: Apply for RFA DK 23 515

This funding opportunity (RFA DK 23 515) is a National Institutes of Health (NIH) cooperative agreement (U01) designed to keep the existing Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) clinical centers operating while they finish ongoing clinical treatment trials and continue long-term, systematic collection of patient data and biospecimens. The emphasis is on sustaining the clinical site infrastructure that supports active studies and the network's longitudinal NAFLD database work involving both children and adults diagnosed across the spectrum of nonalcoholic fatty liver disease (NAFLD), including simple steatosis, nonalcoholic steatohepatitis (NASH), and NAFLD-related cirrhosis. Because the mechanism is a U01 cooperative agreement and explicitly states "Clinical Trial Required," awardees should expect substantial NIH program involvement and an expectation that funded sites will carry out the clinical trial-related responsibilities and network protocols rather than operating as fully independent investigator-initiated projects.

Programmatically, the NOFO is positioned as a continuation of a long-running, NIDDK-sponsored national research network that began in 2002 and was renewed in 2009 and 2014. The NASH CRN has historically targeted major unanswered questions about NASH and related NAFLD conditions, including causes and contributing factors, disease progression and natural history, complications, and treatment approaches. This continuation notice focuses on enabling the network to complete active trials already underway and to preserve the value of long-term follow-up by continuing to gather standardized clinical information and biospecimens over time. In practice, that typically means maintaining consistent enrollment and retention practices, ensuring high-quality data capture, supporting protocol-driven visits and assessments, and managing biospecimen handling so that samples remain usable for current analyses and future research questions.

The opportunity is described as a limited competition, meaning it is not structured as a wide-open solicitation for entirely new centers or new, unrelated projects, but rather as a mechanism to keep the established network clinical sites supported during a defined period of continued trial completion and longitudinal follow-up. The funding activity category is listed under Food and Nutrition, Health, with CFDA number 93.847, and the sponsoring agency is NIH (with the network historically sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK). The original application closing date provided is 2023-11-08, and an award ceiling of $250,000 is listed in the source data.

Eligibility is broad across many domestic organization types, spanning state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (outside of higher education); for-profit organizations (other than small businesses); small businesses; and other categories. The notice also explicitly calls out additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments other than federally recognized, and U.S. territories or possessions. At the same time, the NOFO draws clear limits around foreign involvement: non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply, and foreign components (as defined by NIH policy) are not allowed.

Overall, the core purpose is continuity and completion: keeping NASH CRN clinical centers funded so they can finish active treatment trials and protect the long-term scientific value of the network by continuing standardized, longitudinal NAFLD data and biospecimen collection across pediatric and adult populations. This structure supports consistent multi-site methods, preserves long-term cohorts, and enables ongoing analyses of disease drivers, progression, outcomes, and therapeutic responses in a way that single-site studies usually cannot match.

  • The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "Limited Competition for the Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Clinical Centers (U01 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
  • This funding opportunity was created on 2023-09-07.
  • Applicants must submit their applications by 2023-11-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $250,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DK 23 515

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition, Health

Next opportunity: OIA Coral Reef and Natural Resources Program 2024

Previous opportunity: Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DK 23 515

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DK 23 515) also looked into and applied for these:

Funding Opportunity
Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers (U01 Clinical Trial Required) Apply for RFA DK 23 017

Funding Number: RFA DK 23 017
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Apply for PAR 23 275

Funding Number: PAR 23 275
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required) Apply for RFA DA 24 034

Funding Number: RFA DA 24 034
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA DK 23 004

Funding Number: RFA DK 23 004
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $750,000
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) Apply for RFA DK 25 003

Funding Number: RFA DK 25 003
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $750,000
Single Source for continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed) Apply for RFA DK 25 002

Funding Number: RFA DK 25 002
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $2,000,000
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional) Apply for RFA DK 25 001

Funding Number: RFA DK 25 001
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Cardiovascular Repository Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Allowed). Apply for RFA DK 23 021

Funding Number: RFA DK 23 021
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $600,000
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed) Apply for PAR 24 074

Funding Number: PAR 24 074
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $100,000
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed) Apply for PAR 24 102

Funding Number: PAR 24 102
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) Apply for PAR 24 094

Funding Number: PAR 24 094
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $225,000
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 24 103

Funding Number: PAR 24 103
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required) Apply for RFA DK 23 011

Funding Number: RFA DK 23 011
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed) Apply for RFA DK 25 013

Funding Number: RFA DK 25 013
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional) Apply for PAS 24 163

Funding Number: PAS 24 163
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed) Apply for RFA MD 24 005

Funding Number: RFA MD 24 005
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed) Apply for PAR 24 162

Funding Number: PAR 24 162
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Diabetes Research Centers (P30 Clinical Trial Optional) Apply for RFA DK 25 008

Funding Number: RFA DK 25 008
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) Apply for RFA DK 23 007

Funding Number: RFA DK 23 007
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $550,000
Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional) Apply for RFA DK 24 002

Funding Number: RFA DK 24 002
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 23 515", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: